Aptamer Group PLC - York-based biotech firm - Signs material agreement with unnamed biotechnology company, focused on developing genetic medicines. Aptamer will use its platform to discover Optimer.
Aptamer Group PLC on Thursday announced a cost-cutting drive as it aims to break even within two years.
The York-based biotech firm that makes synthetic antibodies capable of binding to targets such.
Aptamer Group PLC announced that it had terminated its sale process after announcing it had conditionally completed a fundraise, while the company also revealed that its chair and interim chief.